|
KIF23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.638360E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.903400E-01 |
| Normal-vs-Stage2 |
7.363200E-01 |
| Normal-vs-Stage3 |
1.620250E-02 |
| Normal-vs-Stage4 |
5.653600E-02 |
| Stage1-vs-Stage2 |
8.714000E-01 |
| Stage1-vs-Stage3 |
3.774200E-02 |
| Stage1-vs-Stage4 |
4.836400E-02 |
| Stage2-vs-Stage3 |
1.162820E-01 |
| Stage2-vs-Stage4 |
7.883900E-02 |
| Stage3-vs-Stage4 |
6.278200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.164240E-01 |
| Normal-vs-AfricanAmerican |
6.542200E-02 |
| Normal-vs-Asian |
2.035400E-01 |
| Caucasian-vs-AfricanAmerican |
4.229200E-01 |
| Caucasian-vs-Asian |
5.546800E-01 |
| AfricanAmerican-vs-Asian |
7.610200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.450200E-01 |
| Normal-vs-Female |
3.276000E-03 |
| Male-vs-Female |
1.558230E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.207800E-02 |
| Normal-vs-Extreme_Weight |
5.943800E-01 |
| Normal-vs-Obese |
1.507450E-01 |
| Normal-vs-Extreme_Obese |
9.236400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.894000E-02 |
| Normal_Weight-vs-Obese |
3.606600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.296610E-01 |
| Extreme_Weight-vs-Obese |
3.443600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.625200E-01 |
| Obese-vs-Extreme_Obese |
4.766000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.138400E-03 |
| Normal-vs-Age(41-60Yrs) |
6.696700E-03 |
| Normal-vs-Age(61-80Yrs) |
5.565600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.428600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.631700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.083100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.560800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.734400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.606000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.320400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.538200E-01 |
| Normal-VS-Type2 PRCC |
2.766800E-01 |
| Normal-VS-KIRP CIMP |
5.021600E-03 |
| Normal-VS-Unclassified PRCC |
5.106000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.850800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.580900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.451400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.91260000000404E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
8.042200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.535600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.606800E-01 |
| Normal-vs-N1 |
8.960800E-04 |
| Normal-vs-N2 |
3.583600E-01 |
| N0-vs-N1 |
1.696540E-03 |
| N0-vs-N2 |
2.264600E-01 |
| N1-vs-N2 |
3.894600E-01 |
|
|
